| Financial Year |
March 31 2023 |
| Monetary Funds |
1,228,432,215.96 |
| Held-for-trading Financial Assets |
1,009,481,895.03 |
| Notes Receivable |
-- |
| Accounts Receivable |
766,324,934.28 |
| Advances to Suppliers |
18,964,214.87 |
| Other Receivables |
28,619,235.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,658,091.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,529,481.52 |
| Total Current Assets |
3,172,010,069.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
224,750,319.54 |
| Fixed Assetes |
662,218,278.20 |
| Under-construction Projects |
47,067,726.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,561,340.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,522.19 |
| Other Non-Current Assets |
1,186,424.00 |
| Sub-Total of Non-Current Assets |
1,058,016,060.31 |
| Total Assets |
4,230,026,129.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,059,941,460.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
158,563,686.53 |
| Taxes Payable |
5,536,345.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,093,948.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
265,544.77 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,452,630,405.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
321,693,129.88 |
| Total Liabilities |
1,774,323,535.86 |
| Paid-In Capital(Or Share Stock) |
353,523,000.00 |
| Capital Surplus |
877,096,632.62 |
| Surplus Reserve |
148,119,046.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,074,057,672.31 |
| Minority Stockholder's Interest |
3,499,782.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,452,202,811.26 |
| Owner's Equity（Stockholder's Equity） |
2,455,702,594.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,230,026,129.90 |
